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Coronary artery disease (CAD) accounts for a large
fraction of the morbidity and mortality in patients with
type 2 diabetes mellitus (T2DM). T2DM is recognized as
a CAD risk factor [1]. Patients with T2DM are also at
greater risk for silent ischemia and infarction, with a
higher prevalence of multi-vessel CAD. Delayed identi-
fication of CAD in patients with T2DM unquestionably
worsens their prognoses. Thus, there is a clear need to
identify patients with T2DM who are at risk for cardio-
vascular events before the onset of symptoms, although
the utility of screening patients with T2DM for asympto-
matic coronary atherosclerosis remains debatable.
About 11 years ago, the American Diabetes Association
suggested a risk factor-guided screening approach (e.g.,
considering age, gender, hypertension, and dyslipidemia)
for early detection of CAD in patients with symptomatic
and asymptomatic T2DM [2]. However, subsequent
studies have shown that the traditional risk factors do not
accurately predict the risk for cardiovascular events in
T2DM patients [3]. This provides a rationale for an
aggressive screening approach for CAD in asymptomatic
patients with T2DM, almost independent of other risk
factors. Nevertheless, there is no uniform policy regarding
CAD screening in patients with T2DM, reflecting the
statistical challenges of screening patients at low risk and
the decisions that should be made from the resulting data.
Generally, a resting electrocardiogram (ECG) and resting
echocardiography are incapable of detecting asymptomatic
CAD. Indeed, stress tests are needed for the early detection
of CAD. 
The exercise ECG test is a popular stress test that has
good accessibility and relatively low-cost. An exercise ECG
test is an established method in subjects with known
CAD, but its diagnostic accuracy is low in individuals with
early atherosclerosis. Furthermore, few data exist on the
relationship between exercise ECG test results and CAD
risk in persons with T2DM, and most studies have involved
small samples. Recently, William et al. [4] studied 2854
men with documented T2DM and showed that equivocal
and abnormal exercise ECG responses in diabetic patients
were associated with higher risk for all-cause cardio-
vascular disease and CAD mortality. William et al. [4]
strongly recommended performing an exercise ECG test
in patients who have had T2DM for ≥10 years and who
have any family history of cardiovascular disease.
Although recent studies regarding the exercise ECG test
have shown good results for the early detection of CAD
in diabetic patients, its value in diabetic patients is limited,
because its low sensitivity requires a workload that is
difficult to achieve in diabetic patients owing to co-
morbidities such as peripheral neuropathy, peripheral
arterial diseases, and poor physical fitness.
There is abundant evidence that carotid intima-media
thickness (c-IMT) is a surrogate marker of subclinical
CAD in both the general population and in patients with
T2DM. Wagenknecht et al. [5] showed that the progression
of c-IMT was 25% greater in diabetic subjects than in non-
diabetic subjects. However, the measurement of c-IMT is
an operator-dependent technique, making intra- and
inter-observer variability an issue. Furthermore, there are
no widely accepted age- and gender-adjusted reference
ranges for c-IMT.
Newer imaging methods such as myocardial perfusion
scintigraphy using single-photon emission computed
tomography (SPECT) and cardiac computed tomography
angiography (CCTA) allow direct quantification of the
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See Article on Page 183-189coronary atherosclerotic burden and can predict the risk
for cardiac events. Thus, these imaging tools are available
for the early detection of coronary atherosclerosis.
Myocardial SPECT with pharmacological stress has
proved to be valuable in detecting silent CAD in asymp-
tomatic diabetic patients, and its diagnostic accuracy is
fairly high [6]. Although SPECT is more expensive than
an exercise ECG test, its higher accuracy and lower non-
diagnostic rate may make it a more cost-effective initial
screening test. This functional imaging technique, however,
does not always correlate with the anatomic situation and
shows suboptimal sensitivity and specificity. Additionally,
this technique cannot show the unstable plaque responsible
for acute coronary syndrome. Recently, in a randomized
controlled study, cardiac event rates were low and were
not significantly reduced by myocardial SPECT screening
for myocardial ischemia [7].
Non-invasive anatomic imaging such as CCTA with
coronary artery calcium scoring can provide direct
visualization of the coronary artery and has emerged as an
alternative modality for the detection of occult CAD.
However, most individuals with CAD have a plaque
burden composition characterized by a combination of
different types of plaque. Importantly, the role of coronary
imaging in diabetic patients is not to document the
presence of coronary atherosclerosis, but to identify those
patients with more extensive disease who may benefit
from further testing to reveal significant inducible
myocardial ischemia [8]. Eventually, better imaging
techniques will be needed to assess both the degree of
plaque burden (soft and calcified) and the extent of
vulnerable plaques.
The combined use of anatomic atherosclerosis imaging
and functional imaging is emerging as a complementary
strategy [9], but the clinical application and cost-
effectiveness of such an approach must be evaluated in
prospective trials. For a screening test to be useful, the
following conditions must be satisfied [10]: (i) it should be
commonly available and relatively low-cost (cardiac
SPECT and CCTA are expensive diagnostic tools), with a
cost-effectiveness analysis of the screening process; (ii)
it should have high positive and negative predictive values
(the ability of myocardial SPECT to identify low-risk
diabetic patients may not be as accurate, and the true
prevalence of CAD in asymptomatic T2DM is unknown);
and (iii) it should dictate decisions in clinical management
that change the natural history of the disease (unfortu-
nately, there is no randomized controlled study comparing
treatment strategies in asymptomatic diabetic patients).
Based on their well-designed clinical study, Yoo et al.
recommended the use of an exercise ECG test for the early
detection of asymptomatic CAD in patients who have had
T2DM for ≥10 years and who have a family history of
cardiovascular disease. From a clinical view point, this
recommendation is meaningful because some factors do
contribute to the early detection of asymptomatic CAD in
T2DM. However, this study had some limitations. First,
the number of study subjects was too small to obtain
statistical significance. Second, the exercise ECG test has
limited value in detecting early CAD, because of its low
sensitivity. Third, the exercise ECG test may not be
applicable in T2DM patients with autonomic dysfunction
and/or physical unfitness. Thus, the clinical usefulness of
an exercise ECG test as a tool for the early detection of
asymptomatic CAD in T2DM should be cautiously
interpreted. 
In conclusion, there is still no convincing evidence that
screening programs to prevent cardiovascular events in
patients with T2DM are cost-effective. Despite many
uncertainties, however, we have highlighted some key
points underlying the rationale for screening this high-risk
population for heart disease. The detection of silent CAD
in patients with T2DM will become an even greater public
health issue in the future, as the number of people with
T2DM increases. There are sound arguments on both
sides of this issue, and the controversy can only be resolved
by gathering more evidence from randomized controlled
clinical trials. (Korean J Intern Med 2009;24:180-
182)
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